Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 6, 2016

View Archived Issues

Concomitant pan-Raf/PI3K inhibition as promising new therapeutic strategy in multiple myeloma

Hsa-miR-623 suppresses lung adenocarcinoma cell proliferation and invasion

miR-558 and Smad4 as novel therapeutic targets for gastric cancer

Ang-Tie-2 interventions as potential adjunctive therapeutics for severe malaria

Sumitomo Dainippon Pharma develops PDE1 inhibitors

Wuhan LL Science and Technology Development announces nitric oxid donors

Sarepta licenses European rights to Summit's utrophin modulator pipeline for DMD

Gene therapy as a promising new approach for treating cystic fibrosis lung disease

Tenax Therapeutics provides clinical update for levosimendan

Achilles Therapeutics launched to develop immunotherapies for cancer

Redhill Biopharma commences phase II study of Yeliva in HCC

Insmed and AstraZeneca enter worldwide license agreement

Triphase Accelerator obtains rights to ADC from Catalent Biologics

Mitsubishi Tanabe and Daiichi Sankyo announce progress in malaria research programs with MMV

Gilead initiates phase II trial of GS-9876 in patients with active rheumatoid arthritis

MD Anderson initiates first-in-human study of IACS-010759 in relapsed or refractory AML

New company Kymo Therapeutics formed to advance KMO inhibitors

DTX-401 named FDA orphan drug for treating glycogen storage disease type Ia

Scynexis reports full results from phase II studies of antifungal SCY-078

Alnylam Pharmaceuticals discontinues development of revusiran

Cepheid launching Xpert Bladder Cancer Monitor in Europe

Immunomic Therapeutics and Nature Technology Corporation announce new license agreement

FDA warns on risk of HBV reactivation in patients taking direct-acting antivirals for HCV

Helmholtz-Zentrum fur Infektionsforschung develops lecB inhibitors

Toray Industries prepares and tests agents for urinary incontinence

Almirall patents Nav1.7 channel blockers for pain

Novira Therapeutics describes agents for HBV infection

Exosome Diagnostics and Amgen partner on liquid biopsy diagnostics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...